High-Dose Buprenorphine Induction in ED Seems Safe for Treating OUD
High-dose buprenorphine protocol well tolerated in patients with untreated opioid use disorder; no reports of respiratory depression or sedation
Restrictive Eating Disorders Up Among Teens During Pandemic
For first 12 months of pandemic, number of admissions at children's hospital more than double for same period in previous three years
Two Major Health Systems Will Not Administer Controversial Aduhelm
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
Rx Treatment for Opioid Use Disorder Up Among Medicaid Enrollees
There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
U.S. Drug Overdose Deaths Up ~30 Percent in 2020
Increases seen in overdose deaths from opioids, as well as cocaine and psychostimulants
Late-Life Cognitive Activity May Delay Dementia
Taking up reading, puzzles, and games even in one's 80s may provide cognitive protection
Rahul Gupta to Be Nominated as Next U.S. Drug Czar
Gupta was the former health commissioner of West Virginia and is chief medical and health officer for the March of Dimes
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
AAN Presents Ethical Considerations Relating to Dementia Care
Timely anticipatory planning in early dementia is crucial to preserve autonomy over future decisions and to reduce caregiver strain
Androgenetic Alopecia May Reduce Health-Related Quality of Life
Authors say patients with androgenetic alopecia may need psychological, psychosocial support
